查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1972103

超音波针市场：按产品类型、规格、应用和最终用户划分 - 2026-2032年全球预测

Endoscopic Ultrasound Needles Market by Product Type, Gauge, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，内视镜超音波针市场价值将达到 1.8591 亿美元，到 2026 年将成长至 1.9848 亿美元，到 2032 年将达到 2.8699 亿美元，复合年增长率为 6.39%。

主要市场统计数据
基准年 2025 1.8591亿美元
预计年份：2026年 1.9848亿美元
预测年份 2032 2.8699亿美元
复合年增长率 (%) 6.39%

为策略决策者提供关于重塑内视镜超音波针市场的不断变化的临床、技术和商业性因素的简明概述。

内视镜超音波针在胃肠病学、呼吸内科和肿瘤学领域发挥着至关重要的作用，弥合了诊断准确性和微创治疗之间的差距。影像品质的提高、组织取样技术的进步以及与周边设备的集成，不断提升了临床医生对这些设备的期望，推动了设计、材料科学和手术流程的创新。临床医生日益关注可靠的组织学取样、与分子分析的兼容性以及能够在保障患者安全的同时缩短手术时间。因此，产品开发、临床实践、采购和医院管理等相关人员必须应对不断变化的临床终点和经济需求。

技术的整合、流程的标准化以及不断变化的临床期望，共同重新定义了设备设计、培训和商业性重点。

内视镜超音波针领域正经历着一场变革，其驱动力包括技术融合、操作流程标准化以及人们对更精准诊断日益增长的需求。穿刺针的设计不再局限于简单的规格和形状选择，而是涵盖了先进的工程技术、针芯创新以及采用分子保存优化的材料。这些设备层面的改进与先进的显像模式和软体工具相结合，为内视镜医师提供即时回馈，从而降低取样变异性，并提高组织取样的可靠性。

对 2025 年关税调整对医疗设备。

近期影响医疗设备的关税政策和贸易措施，为依赖国际供应链的製造商、经销商和医疗保健系统带来了新的挑战。 2025年的关税调整改变了部分进口零件和成品的到岸成本，迫使采购团队重新评估其筹资策略和库存缓衝。这些政策变化不仅直接影响单价，也凸显了考虑总到岸成本（包括运费、关税和运输时间风险）的重要性。提前建立关税情境模型的企业在与供应商谈判合约、外汇风险以及优化配送中心方面更具优势。

对抽吸针和切片穿刺针的使用案例进行清晰的细分，可以指导产品设计、临床证据策略和商业性定位。

细分市场分析能够明确临床需求与产品功能最契合的领域，有助于确定研发和商业化工作的优先顺序。根据产品类型，市场被划分为细针穿刺针和细针活检针两大类。细针穿刺针在以细胞学为中心的临床工作流程中仍然十分有用，因为这类流程优先考虑的是快速现场评估和细胞采集量。另一方面，细针活检针在组织结构保存和与分子检测的兼容性至关重要的场景中越来越受欢迎。这种差异会影响器械的特性，例如管腔设计、针尖形状和组织保留能力。

美洲、欧洲、中东和非洲以及亚太地区面临的区域差异化挑战正在决定采用率、监管策略和商业性重点。

区域趋势在全球范围内对临床实践模式、监管路径、报销框架和供应链结构的影响各不相同。在美洲，手术量、医院网路和私人保险模式会影响采购週期以及对那些展现出手术效率和明确临床价值的器械的优先选择。临床医生的训练路径以及与学术研究机构的合作会影响新型针头技术的早期应用，而区域报销政策则可能根据证据阈值加速或限制其应用。

产品系列的深度、有针对性的临床证据和策略性商业伙伴关係如何影响竞争优势和市场接受度？

内视镜超音波针领域的竞争动态以快速渐进式创新、策略伙伴关係以及日益重视提供临床差异化证据为特征。领先的供应商倾向于投资于产品线的深度拓展（提供各种规格、针尖形状和配件），同时致力于扩展临床支援体系，以缩短学习曲线。与学术机构、介入性内视镜学会和病理学团体开展合作十分普遍，这使得製造商能够收集可靠的临床数据，并根据实际操作经验改进使用说明。

为开发人员、临床领导者和采购团队提供可操作的策略方法，以加快部署速度、降低供应风险并展现临床价值。

产业领导者应采取多管齐下的方法，将产品创新、切实可行的商业策略和临床合作结合。首先，优先考虑能够显着提高下游分子检测组织品质的设备功能，并使产品宣称和临床研究与这些功能性宣称保持一致。其次，投资于医生培训项目，包括模拟、指导和能力评估，以加快安全部署并减少结果的差异。第三，制定报销材料和卫生经济学分析，量化手术效率的提升和潜在的再治疗减少，以支持与支付者和医院采购团队进行价值评估的讨论。

采用以证据为导向的混合方法，结合临床文献整合、相关人员访谈和供应链分析，以检验策略见解。

本分析的调查方法结合了对临床文献、监管申报文件和器械标籤的系统性回顾，以及有针对性的初步调查，以检验关键主题。在整合临床证据时，我们将重点放在报告诊断效用、分子检测组织合格和併发症率的随机对照试验，以及前瞻性註册研究和高品质队列分析。监管路径分析纳入了上市前申报摘要和上市后监测数据，以确定不同司法管辖区通用的证据要求和时间节点的考量。

一项简洁、综合的分析，结合了技术进步、不断发展的临床实务和采购要求，指导下一个策略重点。

总而言之，内视镜超音波针市场正处于一个转折点，设计创新、实证临床应用和稳健的供应链实践在此交汇融合。能够保护组织结构以进行现代分子诊断的设备层面改进不再是差异化因素，而是成为基本要求。同时，对操作流程标准化和临床医生能力的投入对于实现创新穿刺针所承诺的临床效益至关重要。商业性成功取决于产品宣称与严谨的临床数据相符，并在操作效率和诊断准确性方面展现出实际价值。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 内视镜超音波针市场：依产品类型划分

  • 穿刺切片穿刺针
  • 细针吸针
  • 细针切片针

第九章 内视镜超音波针市场（依规格划分）

  • 19号口径
  • 22号口径
  • 25号口径

第十章 内视镜超音波针市场：依应用领域划分

  • 消化道
  • 肝臟疾病及邻近病变
  • 肺/支气管/纵膈
  • 淋巴结评估
  • 胰臟疾病

第十一章 内视镜超音波针市场：依最终用户划分

  • 门诊手术中心
  • 诊断检查室/诊断影像中心
  • 医院
  • 专科诊所/诊断中心

第十二章 内视镜超音波针市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 内视镜超音波针市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 内视镜超音波针市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国内视镜超音波针市场

第十六章：中国内窥镜超音波针市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Advance Medical Designs, Inc.
  • Aspen Surgical
  • Becton, Dickinson, and Company
  • BIRR
  • Boston Scientific Corporation
  • CIVCO Medical Technologies
  • Conmed Corporation
  • Cook Medical LLC
  • ERBE Elektromedizin GmbH
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Geoteck Medical
  • Hologic Inc.
  • HOYA Corporation
  • Medico's Hirata, Inc.
  • Medtronic plc
  • Olympus Corporation
  • SonoTip GmbH
  • US Endoscopy Group, Inc.
Product Code: MRR-2B5802CFEB55

The Endoscopic Ultrasound Needles Market was valued at USD 185.91 million in 2025 and is projected to grow to USD 198.48 million in 2026, with a CAGR of 6.39%, reaching USD 286.99 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 185.91 million
Estimated Year [2026] USD 198.48 million
Forecast Year [2032] USD 286.99 million
CAGR (%) 6.39%

A concise orientation to the evolving clinical, technological, and commercial drivers reshaping the endoscopic ultrasound needles landscape for strategic decision-makers

Endoscopic ultrasound needles occupy a pivotal role at the intersection of diagnostic precision and minimally invasive therapy within gastroenterology, pulmonology, and oncology practice. Advances in imaging fidelity, tissue acquisition techniques, and ancillary device integration have elevated the clinical expectations placed on these devices, driving innovation across design, materials science, and procedural workflows. Clinician demand is increasingly shaped by the need for reliable histologic sampling, molecular profiling compatibility, and devices that reduce procedural time while maintaining patient safety. Consequently, stakeholders from product development, clinical affairs, procurement, and hospital administration must align around evolving clinical endpoints and economic imperatives.

This executive summary synthesizes the most relevant technological, regulatory, and commercial developments affecting endoscopic ultrasound needles. It consolidates evidence from clinical literature, regulatory filings, physician interviews, and supply chain assessments to present a coherent view of near-term and structural shifts. The objective is to help executives and clinical leaders prioritize initiatives that improve diagnostic yield, streamline training, optimize inventory strategies, and position their organizations or product portfolios for sustainable adoption. By focusing on practical implications rather than raw projections, this introduction sets the stage for informed decision-making across product, clinical, and commercial domains.

How technological convergence, procedural standardization, and evolving clinical expectations are collectively redefining device design, training, and commercial priorities

The landscape for endoscopic ultrasound needles is undergoing transformative shifts driven by technological convergence, procedural standardization, and heightened expectations for precision diagnostics. Needle design has evolved beyond simple gauge and geometry choices to incorporate tip engineering, stylet innovations, and materials optimized for molecular preservation. These device-level refinements are being integrated with enhanced imaging modalities and software tools that provide real-time feedback to endoscopists, thereby reducing sampling variability and improving confidence in tissue acquisition.

Concurrently, clinical workflows are adapting to prioritize multidisciplinary collaboration and standardized sampling protocols. Pathology labs demand high-quality cores compatible with next-generation sequencing and immunohistochemistry, prompting manufacturers to refine needle lumen design and sample retrieval mechanisms. Training programs and proctoring have intensified, with simulation-based curricula and competency assessments becoming more common to accelerate safe adoption of novel needle types. From a commercial perspective, procurement teams are emphasizing total procedural cost and value-based metrics, influencing purchasing decisions toward devices that demonstrably reduce repeat procedures and downstream resource utilization. Finally, regulatory scrutiny and reimbursement pathways are maturing, requiring companies to present robust clinical evidence and real-world performance data to support differentiation and adoption.

Assessing the practical operational, sourcing, and commercial consequences of the 2025 tariff adjustments on device cost structures and supply chain resilience

Recent tariff policies and trade actions affecting medical devices have introduced new layers of complexity for manufacturers, distributors, and health systems that rely on transnational supply chains. Tariff adjustments in 2025 altered landed costs for certain imported components and finished products, compelling procurement teams to reassess sourcing strategies and inventory buffers. These policy changes have not only influenced direct unit costs but also amplified the importance of total landed cost considerations, including freight, customs brokerage, and time-in-transit risks. Organizations that proactively modeled tariff scenarios were better positioned to negotiate supplier agreements, hedge currency exposures, and optimize distribution footprints.

In response to tariff-driven cost pressures, some manufacturers accelerated localization of critical components or diversified their supplier base to reduce reliance on single-country sourcing. This strategic pivot often required investments in qualifying alternative suppliers, conducting supplemental regulatory submissions where device modifications were necessary, and updating quality assurance protocols to preserve clinical performance. Health systems experienced cascading effects as procurement teams evaluated the trade-offs between cost, lead time, and clinical consistency. In many cases, these dynamics heightened interest in strategic vendor partnerships and value-based contracting mechanisms that align incentives across the supply chain. The cumulative impact of these shifts underscores the need for integrated commercial and operational planning to maintain access to clinically preferred devices while managing cost volatility.

Clear segmentation distinctions between aspiration and biopsy needle use cases that guide product design, clinical evidence strategy, and commercial positioning

Segmentation considerations provide clarity on where clinical needs and product features align most tightly, and they help prioritize development and commercialization efforts. Based on Product Type, market is studied across Fine Needle Aspiration Needles and Fine Needle Biopsy Needles. Fine Needle Aspiration needles remain relevant for cytology-focused workflows where rapid on-site evaluation and cellular yield are prioritized, while Fine Needle Biopsy needles have gained traction where tissue architecture preservation and compatibility with molecular assays are essential. This differentiation informs device attributes such as lumen design, tip profile, and tissue retention capabilities.

Understanding these product-type distinctions enables stakeholders to align clinical studies, training programs, and reimbursement strategies with real-world use cases. Developers benefit from tailoring design and labeling to the primary procedural intent, whether that is high-sensitivity cytologic sampling or core tissue retrieval for histologic and genomic analysis. Concurrently, sales and clinical education teams should frame product value around the specific procedural and diagnostic outcomes each needle type is engineered to support. By integrating segmentation insights into product roadmaps and clinical engagement plans, organizations can more precisely target investments that improve adoption and clinical utility.

Differentiated regional imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine adoption, regulatory strategy, and commercial focus

Regional dynamics shape clinical practice patterns, regulatory pathways, reimbursement frameworks, and supply chain configurations in distinct ways across the globe. In the Americas, procedural volumes, hospital networks, and private payer models influence procurement cycles and the prioritization of devices that demonstrate procedural efficiency and clear clinical benefit. Clinician training pathways and academic center research collaborations are influential in early adoption of novel needle technologies, while regional reimbursement policies can accelerate or temper uptake depending on evidence thresholds.

In Europe, Middle East & Africa, heterogeneity in regulatory processes and public reimbursement systems creates a mosaic of adoption pathways where regional clinical champions and centralized procurement can have outsized influence. Suppliers often need to navigate multiple national regulatory nuances and align evidence generation with country-level health technology assessment requirements. In the Asia-Pacific region, a mix of mature and emerging healthcare systems drives a divergent set of priorities: some markets emphasize cost-competitive solutions and local manufacturing, while others focus on cutting-edge diagnostics and rapid incorporation of advanced biopsies into cancer care pathways. Overall, regional strategies must be tailored to local clinical practices, regulatory expectations, and procurement behaviors to ensure successful market entry and sustainable adoption.

How product portfolio depth, targeted clinical evidence, and strategic commercial partnerships are shaping competitive advantage and adoption dynamics

Competitive dynamics in the endoscopic ultrasound needle space are characterized by rapid incremental innovation, strategic partnerships, and an increasing emphasis on evidence generation to substantiate clinical differentiation. Leading suppliers tend to invest in product line depth-offering a range of gauges, tip configurations, and ancillary accessories-while also expanding clinical support infrastructure to shorten learning curves. Collaboration with academic centers, interventional endoscopy societies, and pathology groups is common, enabling manufacturers to gather robust clinical data and refine instructions for use based on real-world procedural insights.

At the same time, smaller innovators are introducing disruptive design elements aimed at niche problems, such as enhanced tissue retention, reduced blood contamination, or compatibility with advanced molecular workflows. These entrants often pursue targeted clinical studies to gain footholds in specialized segments before broader commercialization. Distribution partnerships and contract manufacturing relationships play a critical role in scaling production and extending geographic reach, particularly in regions with complex regulatory requirements. For medtech companies and health system procurement teams, competitive strategy must therefore balance sustained R&D investment, targeted clinical evidence generation, and operational readiness to support broad clinician adoption.

Actionable strategic initiatives for developers, clinical leaders, and procurement teams to accelerate adoption, mitigate supply risk, and demonstrate clinical value

Industry leaders should adopt a multi-pronged approach that combines product innovation with pragmatic commercial tactics and clinical engagement. First, prioritize device features that demonstrably improve tissue quality for downstream molecular testing, and align labeling and clinical studies with those functional claims. Second, invest in physician training programs that include simulation, proctoring, and competency assessments to accelerate safe uptake and reduce variability in outcomes. Third, develop reimbursement dossiers and health economic narratives that quantify procedural efficiency gains and potential reductions in repeat procedures to support value discussions with payers and hospital procurement teams.

Operationally, firms should diversify sourcing strategies for critical components and pursue regional manufacturing or qualified secondary suppliers to mitigate tariff and logistics risk. Commercial teams will be most effective when they couple clinical evidence with practical implementation support-such as starter kits, inventory planning tools, and joint clinical audits-to lower barriers to adoption. Finally, explore strategic partnerships with pathology service providers and molecular diagnostics firms to create bundled solutions that simplify workflows for end-users and strengthen the value proposition across diagnostic pathways. Taken together, these steps will accelerate clinical acceptance, optimize procurement conversations, and reinforce long-term competitive positioning.

An evidence-driven mixed-methods approach combining clinical literature synthesis, stakeholder interviews, and supply chain analysis to validate strategic insights

The research methodology underpinning this analysis combined a structured review of clinical literature, regulatory filings, and device labeling with targeted primary research to validate key themes. Clinical evidence synthesis emphasized randomized studies, prospective registries, and high-quality cohort analyses that reported on diagnostic yield, tissue adequacy for molecular assays, and complication rates. Regulatory pathway analysis incorporated published summaries of premarket submissions and post-market surveillance data to identify common evidence expectations and timing considerations across jurisdictions.

Primary research included semi-structured interviews with practicing endoscopists, pathologists, hospital procurement leaders, and device development professionals to capture frontline perspectives on device performance, training needs, and procurement priorities. Supply chain assessments evaluated typical sourcing footprints, lead-time sensitivities, and the operational implications of tariff and logistics shifts. Finally, findings were triangulated across data sources and subjected to internal validation checks to ensure consistency and to highlight areas where evidence gaps remain. Limitations include variability in reporting across clinical studies and the evolving nature of regulatory guidance that may change the evidentiary bar over time.

A concise synthesis that integrates technological progress, clinical practice evolution, and procurement imperatives to guide next-step strategic priorities

In sum, the endoscopic ultrasound needle landscape is at an inflection point where design innovation, evidence-based clinical adoption, and resilient supply chain practices intersect. Device-level enhancements that preserve tissue architecture for modern molecular diagnostics are becoming foundational requirements rather than optional differentiators. At the same time, procedural standardization and investment in clinician competency are necessary to realize the clinical benefits that innovative needles promise. Commercial success will hinge on aligning product claims with rigorous clinical data and on demonstrating tangible value in procedural efficiency and diagnostic accuracy.

Strategic leaders must therefore adopt integrated approaches that combine focused R&D, targeted evidence generation, and pragmatic operational planning. By doing so, manufacturers and health systems can reduce variability in diagnostic outcomes, optimize procurement decisions, and position themselves to respond rapidly to regulatory and policy shifts. The path forward is collaborative: valuing interdisciplinary clinical feedback, investing in real-world studies, and building supply chain flexibility will provide the most sustainable route to improved patient care and long-term commercial viability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscopic Ultrasound Needles Market, by Product Type

  • 8.1. Core Biopsy Needles
  • 8.2. Fine Needle Aspiration Needles
  • 8.3. Fine Needle Biopsy Needles

9. Endoscopic Ultrasound Needles Market, by Gauge

  • 9.1. 19 Gauge
  • 9.2. 22 Gauge
  • 9.3. 25 Gauge

10. Endoscopic Ultrasound Needles Market, by Application

  • 10.1. Gastrointestinal Tract
  • 10.2. Liver Diseases and adjacent lesions
  • 10.3. Lung / Bronchial & Mediastinal
  • 10.4. Lymph Node Assessment
  • 10.5. Pancreatic Diseases

11. Endoscopic Ultrasound Needles Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Diagnostic Laboratories / Imaging Centres
  • 11.3. Hospitals
  • 11.4. Specialty Clinics / Diagnostic Centres

12. Endoscopic Ultrasound Needles Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Endoscopic Ultrasound Needles Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Endoscopic Ultrasound Needles Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Endoscopic Ultrasound Needles Market

16. China Endoscopic Ultrasound Needles Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Advance Medical Designs, Inc.
  • 17.6. Aspen Surgical
  • 17.7. Becton, Dickinson, and Company
  • 17.8. BIRR
  • 17.9. Boston Scientific Corporation
  • 17.10. CIVCO Medical Technologies
  • 17.11. Conmed Corporation
  • 17.12. Cook Medical LLC
  • 17.13. ERBE Elektromedizin GmbH
  • 17.14. FUJIFILM Holdings Corporation
  • 17.15. GE HealthCare Technologies Inc.
  • 17.16. Geoteck Medical
  • 17.17. Hologic Inc.
  • 17.18. HOYA Corporation
  • 17.19. Medico's Hirata, Inc.
  • 17.20. Medtronic plc
  • 17.21. Olympus Corporation
  • 17.22. SonoTip GmbH
  • 17.23. US Endoscopy Group, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY CORE BIOPSY NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY CORE BIOPSY NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY CORE BIOPSY NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY FINE NEEDLE BIOPSY NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY FINE NEEDLE BIOPSY NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY FINE NEEDLE BIOPSY NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 19 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 19 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 19 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 22 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 22 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 22 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 25 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 25 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY 25 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GASTROINTESTINAL TRACT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GASTROINTESTINAL TRACT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GASTROINTESTINAL TRACT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LIVER DISEASES AND ADJACENT LESIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LIVER DISEASES AND ADJACENT LESIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LIVER DISEASES AND ADJACENT LESIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LUNG / BRONCHIAL & MEDIASTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LUNG / BRONCHIAL & MEDIASTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LUNG / BRONCHIAL & MEDIASTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LYMPH NODE ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LYMPH NODE ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY LYMPH NODE ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PANCREATIC DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PANCREATIC DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PANCREATIC DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES / IMAGING CENTRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES / IMAGING CENTRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES / IMAGING CENTRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY SPECIALTY CLINICS / DIAGNOSTIC CENTRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY SPECIALTY CLINICS / DIAGNOSTIC CENTRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY SPECIALTY CLINICS / DIAGNOSTIC CENTRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. GCC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GCC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. GCC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 101. GCC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. GCC ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. G7 ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. G7 ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. G7 ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 116. G7 ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. G7 ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. NATO ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. NATO ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NATO ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 121. NATO ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. NATO ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. UNITED STATES ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. CHINA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 130. CHINA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. CHINA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 132. CHINA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)